Counter-regulatory renin–angiotensin system in cardiovascular disease

M Paz Ocaranza, JA Riquelme, L García… - Nature Reviews …, 2020 - nature.com
The renin–angiotensin system is an important component of the cardiovascular system.
Mounting evidence suggests that the metabolic products of angiotensin I and II—initially …

Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure

LB Arendse, AHJ Danser, M Poglitsch, RM Touyz… - Pharmacological …, 2019 - ASPET
Despite the success of renin-angiotensin system (RAS) blockade by angiotensin-converting
enzyme (ACE) inhibitors and angiotensin II type 1 receptor (AT1R) blockers, current …

Natural flavonoids as potential angiotensin-converting enzyme 2 inhibitors for anti-SARS-CoV-2

M Muchtaridi, M Fauzi, NK Khairul Ikram… - Molecules, 2020 - mdpi.com
Over the years, coronaviruses (CoV) have posed a severe public health threat, causing an
increase in mortality and morbidity rates throughout the world. The recent outbreak of a …

Neprilysin inhibitors in heart failure: the science, mechanism of action, clinical studies, and unanswered questions

B Bozkurt, AP Nair, A Misra, CZ Scott, JH Mahar… - Basic to Translational …, 2023 - jacc.org
This article provides a contemporary review and a new perspective on the role of neprilysin
inhibition in heart failure (HF) in the context of recent clinical trials and addresses potential …

Hydrogen sulfide: recent progression and perspectives for the treatment of diabetic nephropathy

HJ Sun, ZY Wu, L Cao, MY Zhu, TT Liu, L Guo, Y Lin… - Molecules, 2019 - mdpi.com
Diabetic kidney disease develops in approximately 40% of diabetic patients and is a major
cause of chronic kidney diseases (CKD) and end stage kidney disease (ESKD) worldwide …

Update on the mechanisms of tubular cell injury in diabetic kidney disease

J Chang, J Yan, X Li, N Liu, R Zheng, Y Zhong - Frontiers in medicine, 2021 - frontiersin.org
Increasing evidence supports a role of proximal tubular (PT) injury in the progression of
diabetic kidney disease (DKD), in patients with or without proteinuria. Research on the …

A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor

M Oz, DE Lorke, N Kabbani - Pharmacology & therapeutics, 2021 - Elsevier
The recent emergence of coronavirus disease-2019 (COVID-19) as a global pandemic has
prompted scientists to address an urgent need for defining mechanisms of disease …

[HTML][HTML] Potential effects and application prospect of angiotensin receptor-neprilysin inhibitor in diabetic kidney disease

X Zhang, Y Zhou, R Ma - Journal of Diabetes and its Complications, 2022 - Elsevier
Diabetic kidney disease (DKD) is one of the main causes of end-stage renal disease
(ESRD) and all-cause mortality in diabetic patients, despite the extensive use of angiotensin …

LCZ696 mitigates diabetic-induced nephropathy through inhibiting oxidative stress, NF-κB mediated inflammation and glomerulosclerosis in rats

M Mohany, AZ Alanazi, F Alqahtani, OM Belali… - PeerJ, 2020 - peerj.com
Background Diabetic nephropathy (DN) is among the most common microvascular
complications of diabetes resulting in end-stage renal disease and therefore search for …

Epigenetic restoration of endogenous Klotho expression alleviates acute kidney injury-diabetes comorbidity

A Kale, H Sankrityayan, AB Gaikwad - Life Sciences, 2022 - Elsevier
Aims The present study aimed at exploring the mechanisms behind Klotho regulation in
hyperglycemia augmented AKI. In addition, epigenetic ways to restore the Klotho expression …